Article Details
Retrieved on: 2019-01-20 16:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Kyn launched in December 2017 with $49 million in first-round funding provided by OrbiMed Advisors and <b>Atlas Venture</b>. In the second deal, Celgene ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here